Anesth Pain Med.  2016 Oct;11(4):380-383. 10.17085/apm.2016.11.4.380.

Late recurarization in the post-anesthetic care unit after total thyroidectomy: A case report

• Kim DW
• Kim BK
• Kim JW
• Kim JD
• Ryu SJ
• Kim DS

• KMID: 2358335
• DOI: http://doi.org/10.17085/apm.2016.11.4.380

Abstract

Residual paralysis, recurarization is defined as a remnant effect of neuromuscular blocking after surgery that can cause postoperative complications. Clinical complications of recurarization include dyspnea, gastric content aspiration, and atelectasis. Therefore, complete recovery of muscle strength at the end of surgery is a significant factor for patient safety. We report a case of a 53-year-old woman who presented with residual paralysis after total thyroidectomy. To improve her condition, we injected sugammadex intravenously in the post-anesthetic care unit. After that, we observed her for 1 hour and her muscle strength gradually recovered. She did not have any symptoms on the next day and was discharged on the 5th post-operative day.

Keyword

Neuromuscular blocking agents; Neuromuscular monitoring; Sugammadex; Train-of-four monitoring

MeSH Terms

Dyspnea
Female
Humans
Middle Aged
Muscle Strength
Neuromuscular Blockade
Neuromuscular Blocking Agents
Neuromuscular Monitoring
Paralysis
Patient Safety
Postoperative Complications
Pulmonary Atelectasis
Thyroidectomy*
Neuromuscular Blocking Agents

Reference

1. Kim KS. Clinical use of sugammadex. Anesth Pain Med. 2011; 6:307–13.

2. Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997; 87:1035–43. DOI: 10.1097/00000542-199711000-00005. PMID: 9366453.

3. Andersen BN, Madsen JV, Schurizek BA, Juhl B. Residual curarisation: a comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand. 1988; 32:79–81. DOI: 10.1111/j.1399-6576.1988.tb02692.x. PMID: 2450441.

4. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology. 1988; 69:272–6. DOI: 10.1097/00000542-198808000-00022. PMID: 2900612.

5. Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth. 2009; 103:115–29. DOI: 10.1093/bja/aep093. PMID: 19468024.

6. Murphy GS, Szokol JW, Franklin M, Marymont JH, Avram MJ, Vender JS. Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesth Analg. 2004; 98:193–200. DOI: 10.1213/01.ANE.0000095040.36648.F7. PMID: 14693617.

7. Buzello W, Nöldge G. Repetitive administration of pancuronium and vecuronium (Org NC 45, Norcuron) in patients undergoing long lasting operations. Br J Anaesth. 1982; 54:1151–7. DOI: 10.1093/bja/54.11.1151. PMID: 6128011.

8. Ohsone J, Yamakage M, Murouchi T. Reversal of neuromuscular blockade and complications of remaining blocking effect. Masui. 2008; 57:838–44. PMID: 18649638.

9. King M, Sujirattanawimol N, Danielson DR, Hall BA, Schroeder DR, Warner DO. Requirements for muscle relaxants during radical retropubic prostatectomy. Anesthesiology. 2000; 93:1392–7. DOI: 10.1097/00000542-200012000-00008. PMID: 11149431.

10. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology. 2008; 109:389–98. DOI: 10.1097/ALN.0b013e318182af3b. PMID: 18719436.

11. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology. 2003; 98:1037–9. DOI: 10.1097/00000542-200305000-00002. PMID: 12717121.

12. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997; 86:765–71. DOI: 10.1097/00000542-199704000-00005. PMID: 9105219.

13. Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail's Clinical Anesthesiology. 5th ed. New York: McGraw-Hill education;2013. p. 226–7.

14. Van Gestel L, Cammu G. Is the effect of sugammadex always rapid in onset? Acta Anaesthesiol Belg. 2013; 64:41–7. PMID: 24191525.